|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||116.19 - 116.72|
|52 Week Range||91.39 - 116.72|
|PE Ratio (TTM)||-23.63|
|Expense Ratio (net)||0.25%|
After success in the company's phase 1/2 trial with BMN 270, an investigational gene therapy for hemophilia A, BioMarin Pharmaceuticals (BMRN) is expected to start phase 3 trials.
With the Edwards Intuity Elite valve system, Edwards Lifesciences aims to offer a minimally invasive therapy to complex aortic stenosis patients.
Of the 18 analysts tracking Southwest Airlines (LUV), six (33.3%) have rated the stock a "strong buy," and another six (33.3%) have recommended a "buy."
Given Apple's stock outperformance this year, it's not surprising to see it at the top of many equity growth funds' holdings.
A total of 20 analysts were analyzing BioMarin Pharmaceuticals in July 2017. Six analysts recommended a “strong buy,” while nine analysts suggested a “buy.”
UAA is covered by 34 Wall Street analysts who together rate the company a 2.9 on a scale of 1.0 for "strong buy" to 5.0 for "sell."
After posting better 1Q17 earnings on April 25, Chipotle's stock price rose to $496.14 by May 16, 2017. Since then, it has experienced downward momentum.
In 1Q17, WellCare Health Plans’ (WCG) Medicaid business reported revenues close to $2.6 billion, which equals year-over-year growth of ~11.8%.
In 1Q17, Baskin-Robbins, which operates under the umbrella of Dunkin' Brands (DNKN), had SSSG of -2.4% in the United States and -2.0% in international markets.
UAA's top line expanded 22% YoY (year-over-year) in fiscal 2016 to $4.8 billion, as compared to its 30% average top-line growth between fiscal 2011 to fiscal 2015.
According to a Reuters consensus, of the 28 analysts tracking Marriott (MAR), five of them (18.0%) have a “strong buy” for the stock.
Marriott's cash dividend ratio was 3.0x at the end of 3Q16, which indicates its ability to sustain dividend payouts.
Same-store sales growth Same-store sales growth (or SSSG), expressed as a percentage, is a measure of the rise in revenue from a company’s existing restaurants over a certain period of…
In 4Q16, Under Armour’s adjusted earnings per diluted share stood at $0.23, which was $0.02 lower than what analysts were expecting.
Under Armour's (UAA) Class A shares are rated 2.3 on a scale of 1.0 for "strong buy" to 5.0 for "sell." Class C shares have a higher rating of 1.0.
International sales account for about 15.0% of UAA’s total sales compared to less than 6.0% in fiscal 2013. It has plans to further expand that business.
For the next four quarters, analysts are expecting Wendy's to post EPS growth of $0.40, which represents a decline of 4.2% from the corresponding quarters of the previous year.
Since the announcement of its 2Q16 results on August 10, 2016, Shake Shack (SHAK) EV-to-sales multiple has fallen from 5.1x to 3.7x.
Analysts expect Chipotle to post EPS growth of 146% in the next four quarters. Its current share price might have factored in the growth rate.
Starbucks, a company that operates coffeehouse chains across the world, is scheduled to post its fiscal 4Q16 earnings results after the market closes on November 3, 2016.
Edwards Lifesciences revised its 2016 guidance after reporting a strong 3Q16. The company maintained its sales guidance for the year at the high end of the $2.7 billion–$3 billion range.
Under Armour's massive fall was a result of a warning that came from the company’s management regarding a slowdown in sales growth over the next two years.